ali
Showing 1 - 4 of 4
SARS-CoV 2, COVID, ARDS Trial in United States (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or
Terminated
- SARS-CoV 2
- +5 more
- ZYESAMI™ (aviptadil acetate)
- +2 more
-
Fullerton, California
- +12 more
Feb 2, 2023
SARS-CoV 2, COVID, ARDS Trial (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo)
Withdrawn
- SARS-CoV 2
- +5 more
- ZYESAMI™ (aviptadil acetate)
- +2 more
- (no location specified)
Feb 2, 2023
Covid19, ARDS, Human, ALI Trial in Lund
Recruiting
- Covid19
- +2 more
-
Lund, Skåne Län, SwedenRegion Skåne
Apr 4, 2022
Acute Lung Injury, ALI, COVID-19 Trial in Detroit (RLS-0071 10 mg/kg, RLS-0071 40 mg/kg, Placebo)
Withdrawn
- Acute Lung Injury
- +2 more
- RLS-0071 10 mg/kg
- +2 more
-
Detroit, MichiganHenry Ford Health Systems
Jan 20, 2022